Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
06/28/2000 | EP1012309A2 Chimeric polypeptides containing chemokine domains |
06/28/2000 | EP1012308A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
06/28/2000 | EP1012306A2 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use |
06/28/2000 | EP1012305A1 Component of bromelain |
06/28/2000 | EP1012304A1 Component of bromelain |
06/28/2000 | EP1012303A1 Factor x deletion mutants and analogues thereof |
06/28/2000 | EP1012302A1 Human nucleotide pyrophosphohydrolase |
06/28/2000 | EP1012300A1 Hnk-1 sulfotransferase and methods of use therefor |
06/28/2000 | EP1012296A2 Mammalian thioredoxin |
06/28/2000 | EP1012293A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
06/28/2000 | EP1012292A1 Ntn-2 member of tnf ligand family |
06/28/2000 | EP1012291A1 Multiple site delivery of adenoviral vector for the induction of angiogenesis |
06/28/2000 | EP1012290A1 EXPRESSION OF GONADOTROPINS IN $i(DICTYOSTELIUM) |
06/28/2000 | EP1012288A1 Novel human cystatin-like protein |
06/28/2000 | EP1012287A1 Synthetic polypeptide for diagnosing and treating prion-related diseases |
06/28/2000 | EP1012286A2 Allelic variant of human stat3 |
06/28/2000 | EP1012285A1 Beta-defensins |
06/28/2000 | EP1012284A1 Mpl ligand analogs |
06/28/2000 | EP1012283A1 Mage-3 peptides presented by hla class ii molecules |
06/28/2000 | EP1012282A1 Cysteine rich receptors-train |
06/28/2000 | EP1012281A2 Human leukocyte calcium activated potassium channel polypeptide |
06/28/2000 | EP1012280A1 Trimerising module |
06/28/2000 | EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them |
06/28/2000 | EP1012277A2 Syndecan interacting proteins and the use thereof |
06/28/2000 | EP1012275A1 Chimeric antibody fusion proteins for the recruitment and stimulation of an antitumor immune response |
06/28/2000 | EP1012273A2 Secreted proteins and polynucleotides encoding them |
06/28/2000 | EP1012272A1 Human apoptosis-associated protein; encoding dna is similar to p53 response mouse gene ei124 |
06/28/2000 | EP1012270A2 Kay - a novel immune system protein |
06/28/2000 | EP1012267A2 An antisense oligonucleotide preparation method |
06/28/2000 | EP1012266A1 Galectin 8, 9, 10 and 10sv |
06/28/2000 | EP1012263A1 Secreted proteins and polynucleotides encoding them |
06/28/2000 | EP1012262A1 Human frezzled-like protein |
06/28/2000 | EP1012261A1 Secreted proteins and polynucleotides encoding them |
06/28/2000 | EP1012260A1 Interleukin-20 |
06/28/2000 | EP1012258A1 Dna encoding canine interleukin-1 receptor antagonist |
06/28/2000 | EP1012256A2 Recombinant fusion proteins based on ribosome-inactivating proteins of european mistletoe viscum album |
06/28/2000 | EP1012247A1 Short peptides which selectively modulate intracellular signalling |
06/28/2000 | EP1012242A1 Human sigma receptor |
06/28/2000 | EP1012240A2 Cancer immunotherapy with semi-allogeneic cells |
06/28/2000 | EP1012239A1 Method and system for managing immunocompetent cell batches for delayed use |
06/28/2000 | EP1012238A1 Peptides and peptide-loaded antigen presenting cells for the activation of ctl |
06/28/2000 | EP1012233A1 Transgenically produced prolactin |
06/28/2000 | EP1012232A1 Genetically modified tumor-targeted bacteria with reduced virulence |
06/28/2000 | EP1012191A1 Method for obtaining high-purity vwf or factor viii/vwf complex |
06/28/2000 | EP1012190A1 Eosinophil eotaxin receptor |
06/28/2000 | EP1012189A1 Treatment of obesity |
06/28/2000 | EP1012188A1 Composition for treating diabetes mellitus and obesity |
06/28/2000 | EP1012187A2 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
06/28/2000 | EP1012186A2 Keratinocyte growth factors and uses thereof |
06/28/2000 | EP1012185A1 Retro-inverso neurotrophic and analgesic peptides |
06/28/2000 | EP1012183A1 Peptides comprising an immunodominant sequence derived from human myelin oligodendrocyte glycoprotein |
06/28/2000 | EP1012181A1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
06/28/2000 | EP1012180A2 Hepatitis c inhibitor peptide analogues |
06/28/2000 | EP1012179A2 Cysteine rich receptors: trail |
06/28/2000 | EP1012178A1 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |
06/28/2000 | EP1012177A1 Estrogen receptor |
06/28/2000 | EP1012176A1 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens |
06/28/2000 | EP1012174A1 Nik proteins, nucleic acids and methods |
06/28/2000 | EP1012172A1 Acylated peptide cytolytic peptide inhibitors |
06/28/2000 | EP1012171A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof |
06/28/2000 | EP1012166A1 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
06/28/2000 | EP1012164A1 Serine protease inhibitors |
06/28/2000 | EP1012163A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
06/28/2000 | EP1012162A4 Soluble proteins |
06/28/2000 | EP1012162A1 Soluble proteins |
06/28/2000 | EP1012160A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
06/28/2000 | EP1012157A1 $i(BORRELIA BURGDORFERI) POLYNUCLEOTIDES AND SEQUENCES |
06/28/2000 | EP1012155A1 Human uncoupling protein 3 |
06/28/2000 | EP1011767A1 Device for administering insulin in controlled dosages by controlling total inhaled volume |
06/28/2000 | EP1011743A1 Loading and release of water-insoluble drugs |
06/28/2000 | EP1011733A1 Compositions and methods for enhancing delivery of therapeutic agents to cells |
06/28/2000 | EP1011727A1 Viscous hemostatic composition, in particular in gel state |
06/28/2000 | EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
06/28/2000 | EP1011724A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor |
06/28/2000 | EP1011723A1 88kda tumorigenic growth factor and antagonists |
06/28/2000 | EP1011720A2 Mucosal cytotoxic t lymphocyte responses |
06/28/2000 | EP1011718A1 Anti-viral treatment with pertussis toxin b oligomer |
06/28/2000 | EP1011717A1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same |
06/28/2000 | EP1011716A4 Neuromedin b receptor antagonists |
06/28/2000 | EP1011716A1 Neuromedin b receptor antagonists |
06/28/2000 | EP1011715A1 Inhibin modulation of cell growth |
06/28/2000 | EP1011714A2 Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c |
06/28/2000 | EP1011713A1 Use of interferon alpha subtypes for enhancing immune response |
06/28/2000 | EP1011712A2 Cytokines having neurotrophic activity |
06/28/2000 | EP1011711A1 Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors |
06/28/2000 | EP1011710A1 Methods and compositions for optimization of oxygen transport by cell-free systems |
06/28/2000 | EP1011709A1 Inhibition of apoptotis using prosaposin receptor agonists |
06/28/2000 | EP1011706A1 METHOD TO PREVENT ACCELERATED ATHEROSCLEROSIS USING (sRAGE) SOLUBLE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS |
06/28/2000 | EP1011705A2 Conjugates targeted to the interleukin-2 receptor |
06/28/2000 | EP1011704A1 Tumor necrosis factor receptor-derived peptide analogues |
06/28/2000 | EP1011703A1 Nucleosome-based anti-tumor compositions |
06/28/2000 | EP1011700A1 An oral care composition comprising a bacillus pullulanase and a dextranase |
06/28/2000 | EP1011695A1 Use of neurotoxin therapy for treatment of urologic and related disorders |
06/28/2000 | EP1011694A2 Conditioning for allogeneic stem cell transplantation |
06/28/2000 | EP1011667A1 Antagonists of gonadotropin releasing hormone |
06/28/2000 | EP1011656A2 A method for treating tension-type headache |
06/28/2000 | EP1011654A1 A method of modulating cellular activity |
06/28/2000 | EP1011648A2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
06/28/2000 | EP1011638A1 Small particle liposome aerosols for delivery of anti-cancer drugs |
06/28/2000 | EP1011637A1 Modulation of drug loading in multivesicular liposomes |